KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $50 | -61.2% | 27,840 | -15.8% | 0.00% | -100.0% |
Q1 2023 | $129 | +33.0% | 33,054 | +15.6% | 0.00% | 0.0% |
Q4 2022 | $97 | -99.9% | 28,597 | +22.4% | 0.00% | 0.0% |
Q3 2022 | $128,000 | +161.2% | 23,373 | +115.3% | 0.00% | – |
Q2 2022 | $49,000 | -52.4% | 10,857 | -22.3% | 0.00% | -100.0% |
Q1 2022 | $103,000 | +22.6% | 13,977 | +6.6% | 0.00% | – |
Q4 2021 | $84,000 | -27.0% | 13,107 | +9.0% | 0.00% | -100.0% |
Q4 2017 | $115,000 | +475.0% | 12,030 | +300.2% | 0.00% | – |
Q2 2016 | $20,000 | -4.8% | 3,006 | +24.8% | 0.00% | – |
Q1 2016 | $21,000 | -16.0% | 2,408 | +29.3% | 0.00% | – |
Q4 2015 | $25,000 | 0.0% | 1,863 | -22.7% | 0.00% | – |
Q3 2015 | $25,000 | +19.0% | 2,411 | +216.0% | 0.00% | – |
Q2 2015 | $21,000 | +16.7% | 763 | +28.5% | 0.00% | – |
Q1 2015 | $18,000 | +12.5% | 594 | +37.8% | 0.00% | – |
Q4 2014 | $16,000 | -15.8% | 431 | -21.6% | 0.00% | – |
Q3 2014 | $19,000 | +46.2% | 550 | +95.7% | 0.00% | – |
Q2 2014 | $13,000 | – | 281 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |